cells14.jpg
cells1.jpg
8696879946_c47d0f98fa_o.jpg
cells14.jpg

Discover how far you can go.


SCROLL DOWN

Discover how far you can go.


 

Pharmagellan unlocks the true value in your biotech development pipeline.


Biotech companies typically develop deep research portfolios, but many promising early-stage projects don't progress if the team is stretched thin and focused on the lead asset.

To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.

Pharmagellan offers just that: expert advice and project execution to biotech companies willing to discover how far they can go.

 


Research
& Development

Preclinical, translational, and early clinical strategy and execution

 

commercial
& Corporate

Competitive and financial analysis of products, portfolios, and companies

 
cells1.jpg
SCROLL DOWN
8696879946_c47d0f98fa_o.jpg

Coming in 2016


SCROLL DOWN

Coming in 2016


We're hard at work on our book,

Pharmagellan's Guide to Biotech Financial Modeling 

– the only source you'll need for biopharma forecasting and valuation.

 

Comprehensive guide to financial assessment of development- and commercial-stage drugs, portfolios, and companies

Up-to-date data, references, and "rules of thumb" for revenues, costs, risk adjustment, corporate finance, and more

One-stop handbook for business development / finance professionals, investors, equity analysts, investment bankers, and consultants

 

For news, excerpts, and release / purchasing info, sign up for email updates below.